321 related articles for article (PubMed ID: 21071432)
1. Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome.
Smith LB; Hadoke PW; Dyer E; Denvir MA; Brownstein D; Miller E; Nelson N; Wells S; Cheeseman M; Greenfield A
Cardiovasc Res; 2011 Apr; 90(1):182-90. PubMed ID: 21071432
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice.
Faugeroux J; Nematalla H; Li W; Clement M; Robidel E; Frank M; Curis E; Ait-Oufella H; Caligiuri G; Nicoletti A; Hagege A; Messas E; Bruneval P; Jeunemaitre X; Bergaya S
Hypertension; 2013 Jul; 62(1):203-8. PubMed ID: 23630948
[TBL] [Abstract][Full Text] [Related]
3. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
4. Cervical artery dissections and type A aortic dissection in a family with a novel missense COL3A1 mutation of vascular type Ehlers-Danlos syndrome.
Makrygiannis G; Loeys B; Defraigne JO; Sakalihasan N
Eur J Med Genet; 2015 Nov; 58(11):634-6. PubMed ID: 26497932
[TBL] [Abstract][Full Text] [Related]
5. Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.
Dubacher N; Münger J; Gorosabel MC; Crabb J; Ksiazek AA; Caspar SM; Bakker ENTP; van Bavel E; Ziegler U; Carrel T; Steinmann B; Zeisberger S; Meienberg J; Matyas G
Cardiovasc Res; 2020 Feb; 116(2):457-465. PubMed ID: 31056650
[TBL] [Abstract][Full Text] [Related]
6. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
[TBL] [Abstract][Full Text] [Related]
7. The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.
Cooper TK; Zhong Q; Krawczyk M; Tae HJ; Müller GA; Schubert R; Myers LA; Dietz HC; Talan MI; Briest W
Vet Pathol; 2010 Nov; 47(6):1028-39. PubMed ID: 20587693
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of three Korean patients with clinical features of Ehlers-Danlos syndrome type IV.
Yang JH; Lee ST; Kim JA; Kim SH; Jang SY; Ki CS; Kim DK
J Korean Med Sci; 2007 Aug; 22(4):698-705. PubMed ID: 17728513
[TBL] [Abstract][Full Text] [Related]
9. Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
Gorosabel MC; Dubacher N; Meienberg J; Matyas G
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):199-200. PubMed ID: 31693161
[No Abstract] [Full Text] [Related]
10. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
[TBL] [Abstract][Full Text] [Related]
11. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
[TBL] [Abstract][Full Text] [Related]
12. Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene.
Sadakata R; Hatamochi A; Kodama K; Kaga A; Yamaguchi T; Soma T; Usui Y; Nagata M; Ohtake A; Hagiwara K; Kanazawa M
Intern Med; 2010; 49(16):1797-800. PubMed ID: 20720362
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
Shalhub S; Black JH; Cecchi AC; Xu Z; Griswold BF; Safi HJ; Milewicz DM; McDonnell NB
J Vasc Surg; 2014 Jul; 60(1):160-9. PubMed ID: 24650746
[TBL] [Abstract][Full Text] [Related]
14. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
Kuivaniemi H; Tromp G
Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
[TBL] [Abstract][Full Text] [Related]
15. Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation.
Sakai K; Toda M; Kyoyama H; Nishimura H; Kojima A; Kuwabara Y; Kobayashi Y; Kikuchi S; Hirata Y; Moriyama G; Watanabe W; Akutsu K; Nakai M; Yamada T; Gemma A; Uematsu K
Intern Med; 2019 Dec; 58(23):3441-3447. PubMed ID: 31391389
[TBL] [Abstract][Full Text] [Related]
16. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
[TBL] [Abstract][Full Text] [Related]
17. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
[TBL] [Abstract][Full Text] [Related]
18. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
Chiodo AA; Sillence DO; Cole WG; Bateman JF
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
[TBL] [Abstract][Full Text] [Related]
19. Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency.
Meienberg J; Rohrbach M; Neuenschwander S; Spanaus K; Giunta C; Alonso S; Arnold E; Henggeler C; Regenass S; Patrignani A; Azzarello-Burri S; Steiner B; Nygren AO; Carrel T; Steinmann B; Mátyás G
Eur J Hum Genet; 2010 Dec; 18(12):1315-21. PubMed ID: 20648054
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
